2021
DOI: 10.1186/s12887-021-02765-2
|View full text |Cite
|
Sign up to set email alerts
|

MR-Proadrenomedullin as biomarker of renal damage in urinary tract infection in children

Abstract: Background Midregional-proadrenomedullin (MR-proADM) is a useful prognostic peptide in severe infectious pathologies in the adult population. However, there are no studies that analyze its utility in febrile urinary tract infection (fUTI) in children. An accurate biomarker would provide an early detection of patients with kidney damage, avoiding other invasive tests like renal scintigraphy scans. Our objective is to study the usefulness of MR-proADM as a biomarker of acute and chronic renal par… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 37 publications
(27 reference statements)
0
1
0
Order By: Relevance
“…An MR-proADM level of 1.5–2.0 nmol/L was found to be an independent predictor of MOF-related mortality in adult critically ill patients [ 27 , 31 ]. The cut-off level of MR-proADM for diagnosing kidney damage in urinary tract infections [ 32 ] in children was 0.66 nmol/L, and 0.70 nmol/L was closely related to ICU hospitalization [ 33 ]. Our MR-proADM level of 0.929 nmol/L was slightly higher than reported by the manufacturer and other studies of children [ 32 , 33 ], which may be attributed to the severity of the patients’ illnesses.…”
Section: Discussionmentioning
confidence: 99%
“…An MR-proADM level of 1.5–2.0 nmol/L was found to be an independent predictor of MOF-related mortality in adult critically ill patients [ 27 , 31 ]. The cut-off level of MR-proADM for diagnosing kidney damage in urinary tract infections [ 32 ] in children was 0.66 nmol/L, and 0.70 nmol/L was closely related to ICU hospitalization [ 33 ]. Our MR-proADM level of 0.929 nmol/L was slightly higher than reported by the manufacturer and other studies of children [ 32 , 33 ], which may be attributed to the severity of the patients’ illnesses.…”
Section: Discussionmentioning
confidence: 99%